{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T03:00:09Z","timestamp":1783652409649,"version":"3.55.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2010,5,8]],"date-time":"2010-05-08T00:00:00Z","timestamp":1273276800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bundesgesundheitsbl."],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1007\/s00103-010-1070-7","type":"journal-article","created":{"date-parts":[[2010,5,6]],"date-time":"2010-05-06T07:22:21Z","timestamp":1273130541000},"page":"597-605","source":"Crossref","is-referenced-by-count":10,"title":["Die variante Creutzfeldt-Jakob-Krankheit (vCJK)","Variant Creutzfeld\u2013Jakob disease (vCJD)"],"prefix":"10.1007","volume":"53","author":[{"given":"M.","family":"Beekes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,5,8]]},"reference":[{"key":"1070_CR1","unstructured":"Will RG (2001) Portrait der neuen Variante der Creutzfeldt-Jakob-Krankheit (nvCJD). In: H\u00f6rnlimann B, Riesner D, Kretzschmar H (Hrsg) Prionen und Prionkrankheiten. De Gruyter, Berlin New York, S 152\u2013157"},{"key":"1070_CR2","unstructured":"Will RG, Ironside JW (2006) Portrait of Variant Creutzfeldt-Jakob disease. In: H\u00f6rnlimann B, Riesner D, Kretzschmar H (Hrsg) Prions in humans and animals. De Gruyter, Berlin New York, S 204\u2013209"},{"key":"1070_CR3","doi-asserted-by":"crossref","first-page":"13363","DOI":"10.1073\/pnas.95.23.13363","volume":"95","author":"Prusiner","year":"1998","unstructured":"Prusiner SB (1998) Prions. Proc Natl Acad Sci U S A 95:13363\u201313383","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1070_CR4","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1742-4658.2007.05631.x","volume":"264","author":"Beekes","year":"2007","unstructured":"Beekes M, McBride PA (2007) The spread of prions through the body in naturally acquired transmissbile spongiform encephalopathies. FEBS J 264:588\u2013605","journal-title":"FEBS J"},{"key":"1070_CR5","unstructured":"The European and allied countries collaborative study group of CJD (2010) Cases of vCJD worldwide (as of February 2010). http:\/\/www.eurocjd.ed.ac.uk\/vcjdworldeuro.htm"},{"key":"1070_CR6","doi-asserted-by":"crossref","unstructured":"Beekes M, Mielke M, Kurth R (2002) Aspekte zur Risikoabsch\u00e4tzung und Pr\u00e4vention nosokomialer \u00dcbertragungen der klassischen und varianten CJK. Internist (Berl) 43:738\u2013748","DOI":"10.1007\/s00108-002-0635-4"},{"key":"1070_CR7","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1055\/s-2002-20149","volume":"127","author":"Beekes","year":"2002","unstructured":"Beekes M, Kurth R (2002) BSE und Creutzfeldt-Jakob-Krankheit \u2013 Gesundheitspolitische Bedeutung f\u00fcr die Bundesrepublik Deutschland und Europa. Dtsch Med Wochenschr 127:335\u2013340","journal-title":"Dtsch Med Wochenschr"},{"key":"1070_CR8","unstructured":"Veterinary Laboratories Agency (2010) Cattle TSE surveillance statistics \u2013 General statistics. http:\/\/www.defra.gov.uk\/science\/docs\/sci_tse_stats_gen.pdf"},{"key":"1070_CR9","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/382779a0","volume":"382","author":"Anderson","year":"1996","unstructured":"Anderson RM, Donnelly CA, Ferguson NM et al (1996) Transmission dynamics and epidemiology of BSE in British cattle. Nature 382:779\u2013788","journal-title":"Nature"},{"key":"1070_CR10","doi-asserted-by":"crossref","unstructured":"MacDiarmid SC, Infanger P, H\u00f6rnlimann B (2006) BSE control \u2013 internationally recommended approaches. In: H\u00f6rnlimann B, Riesner D, Kretzschmar H (eds) Prions in animals and humans. De Gryuter, Berlin New York, pp 620\u2013662920","DOI":"10.1515\/9783110200171.10.620"},{"key":"1070_CR11","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(04)16811-6","volume":"364","author":"Peden","year":"2004","unstructured":"Peden AH, Head MW, Ritchie DL et al (2004) Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 364:527\u2013529","journal-title":"Lancet"},{"key":"1070_CR12","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0140-6736(04)15486-X","volume":"363","author":"Llewelyn","year":"2004","unstructured":"Llewelyn CA, Hewitt PE, Knight RS et al (2004) Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 363:417\u2013421","journal-title":"Lancet"},{"key":"1070_CR13","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1016\/S0140-6736(06)69835-8","volume":"368","author":"Wroe","year":"2006","unstructured":"Wroe SJ, Pal S, Siddique D et al (2006) Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated blood transfusion: a case report. Lancet 368:2061\u20132067","journal-title":"Lancet"},{"key":"1070_CR14","unstructured":"Health Protection Agency (2007) Health protection report (19 January 2007): Fourth case of transfusion-associated variant-CJD infection. http:\/\/www.hpa.org.uk\/hpr\/archives\/2007\/news2007\/news0307.htm"},{"key":"1070_CR15","unstructured":"Health Protection Agency (2009) Health protection report (20 February 2009): Post mortem finding of asymptomatic variant Creutzfeldt-Jakob disease abnormal prion protein in a person with haemophilia. http:\/\/www.hpa.org.uk\/hpr\/archives\/2009\/news0709.htm#vcjd"},{"key":"1070_CR16","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1365-2516.2009.02181.x","volume":"16","author":"Peden","year":"2010","unstructured":"Peden A, McCardle L, Head MW et al (2010) Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia. Haemophilia 16:296\u2013304","journal-title":"Haemophilia"},{"key":"1070_CR17","unstructured":"Robert Koch-Institut (2007) Falldefinitionen des Robert Koch-Instituts zur \u00dcbermittlung von Erkrankungs- oder Todesf\u00e4llen und Nachweisen von Krankheitserregern \u2013 Ausgabe 2007. http:\/\/www.rki.de\/cln_178\/nn_200532\/DE\/Content\/Infekt\/IfSG\/Falldefinition\/IfSG\/Falldefinition,templateId=raw,property=publicationFile.pdf\/Falldefinition.pdf"},{"key":"1070_CR18","unstructured":"The National Creutzfeldt-Jakob Disease Surveillance Unit (2010) Seventeenth annual report 2008. Creutzfeldt-Jakob disease surveillance in the UK. http:\/\/www.cjd.ed.ac.uk\/report17.pdf"},{"key":"1070_CR19","unstructured":"Health Protection Agency (2010) Incidence of variant Creutzfeldt-Jakob disease deaths in the UK: January 1994 \u2013 December 2009. http:\/\/www.cjd.ed.ac.uk\/cjdq64.pdf"},{"key":"1070_CR20","unstructured":"Joint UKBTS\/NIBSC Professional Advisory Committee (2009) Postion statement Creutzfeldt-Jakob disease (12 March 2009). http:\/\/www.transfusionguidelines.org.uk\/docs\/pdfs\/dl_ps_vcjd_2009\u201303.pdf"},{"key":"1070_CR21","unstructured":"The National Creutzfeldt-Jakob Disease Surveillance Unit (2010) Figures for the number of vCJD cases and referrals of suspected cases of CJD to the NCJDSU since 1990. http:\/\/www.cjd.ed.ac.uk\/figures.htm"},{"key":"1070_CR22","first-page":"102","volume":"44","author":"Collee","year":"2006","unstructured":"Collee JG, Bradley R, Liberski PP (2006) Variant CJD (vCJD) and Bovine Spongiform Encephalopathy (BSE): 10 and 20 years on: part 2. Folia Neuropathol 44:102\u2013110","journal-title":"Folia Neuropathol"},{"key":"1070_CR23","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0140-6736(09)61568-3","volume":"374","author":"Kaski","year":"2009","unstructured":"Kaski D, Mead S, Hyare H et al (2009) Variant CJD in an individual heterozygous for PRNP codon 129. Lancet 374:2128","journal-title":"Lancet"},{"key":"1070_CR24","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/path.1580","volume":"203","author":"Hilton","year":"2004","unstructured":"Hilton DA, Ghani AC, Conyers L et al (2004) Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J Pathol 203:733\u2013739","journal-title":"J Pathol"},{"key":"1070_CR25","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1136\/bmj.38804.511644.55","volume":"332","author":"Ironside","year":"2006","unstructured":"Ironside JW, Bishop MT, Connolly K et al (2006) Variant Creutzfeldt-Jakob disease: prion protein genotype analysis of positive appendix tissue samples from a retrospective prevalence study. BMJ 332:1186\u20131188","journal-title":"BMJ"},{"key":"1070_CR26","unstructured":"World Health Organization (2006) WHO guidelines on tissue infectivity distribution in transmissible spongiform encephalopathies. http:\/\/www.who.int\/bloodproducts\/cs\/TSEPUBLISHEDREPORT.pdf"},{"key":"1070_CR27","doi-asserted-by":"crossref","first-page":"e8765","DOI":"10.1371\/journal.pone.0008765","volume":"5","author":"Notari","year":"2010","unstructured":"Notari S, Moleres FJ, Hunter SB et al (2010) Multiorgan detection and characterization of protease-resistant prion protein in a case of variant CJD examined in the United States. PLoS One 5:e8765","journal-title":"PLoS One"},{"key":"1070_CR28","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1126\/science.1066838","volume":"294","author":"Valleron","year":"2001","unstructured":"Valleron AJ, Boelle PY, Will R, Cesbron JY (2001) Estimation of epidemic size and incubation time based on age characteristics of vCJD in the United Kingdom. Science 294:1726\u20131728","journal-title":"Science"},{"key":"1070_CR29","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1471-2334-4-26","volume":"4","author":"Boelle","year":"2004","unstructured":"Boelle PY, Cesbron JY, Valleron AJ (2004) Epidemiological evidence of higher susceptibility to vCJD in the young. BMC Infect Dis 4:26","journal-title":"BMC Infect Dis"},{"key":"1070_CR30","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0140-6736(98)24035-9","volume":"352","author":"Hilton","year":"1998","unstructured":"Hilton DA, Fathers E, Edwards P et al (1998) Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease. Lancet 352:703\u2013704","journal-title":"Lancet"},{"key":"1070_CR31","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1136\/bmj.325.7365.633","volume":"325","author":"Hilton","year":"2002","unstructured":"Hilton DA, Ghani AC, Conyers L et al (2002) Accumulation of prion protein in tonsil and appendix: review of tissue samples. BMJ 325:633\u2013634","journal-title":"BMJ"},{"key":"1070_CR32","unstructured":"SEAC (Spongiform Encephalopathies Advisory Committee) (2008) Position statement \u201ePrevalence of subclinical variant Creutzfeldt-Jakob disease infections\u201c. http:\/\/www.seac.gov.uk\/statements\/state-cjd-infections.pdf"},{"key":"1070_CR33","doi-asserted-by":"crossref","first-page":"b1442","DOI":"10.1136\/bmj.b1442","volume":"338","author":"Clewley","year":"2009","unstructured":"Clewley JP, Kelly CM, Andrews N et al (2009) Prevalence of disease related prion protein in anonymous tonsil specimens in Britain: cross sectional opportunistic survey. BMJ 338:b1442","journal-title":"BMJ"},{"key":"1070_CR34","unstructured":"Department of Health (2009) Mapping out the consequences of screening blood donations for PrPSc. http:\/\/www.dh.gov.uk\/prod_consum_dh\/groups\/dh_digitalassets\/documents\/digitalasset\/dh_094803.pdf"},{"key":"1070_CR35","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1098\/rsif.2007.0216","volume":"4","author":"Clarke","year":"2007","unstructured":"Clarke P, Will RG, Ghani AC (2007) Is there the potential for an epidemic of variant Creutzfeldt-Jakob disease via blood transfusion in the UK? J R Soc Interface 4:675\u2013684","journal-title":"J R Soc Interface"},{"key":"1070_CR36","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3201\/eid1301.060396","volume":"13","author":"Dietz","year":"2007","unstructured":"Dietz K, Raddatz G, Wallis J et al (2007) Blood transfusion and spread of variant Creutzfeldt-Jakob disease. Emerg Infect Dis 13:89\u201396","journal-title":"Emerg Infect Dis"},{"key":"1070_CR37","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1098\/rsif.2006.0142","volume":"3","author":"Garske","year":"2006","unstructured":"Garske T, Hester JT, Clarke P et al (2006) Factors determining the potential for onward transmission of variant Creutzfeldt-Jakob disease via surgical instruments. J R Soc Interface 3:757\u2013766","journal-title":"J R Soc Interface"},{"key":"1070_CR38","doi-asserted-by":"crossref","unstructured":"H\u00f6rnlimann B, Pauli G, Lemmer K et al (2006) Prevention of transmission of prion diseases in healthcare settings. In: H\u00f6rnlimann B, Riesner D, Kretzschmar H (Hrsg) Prions in humans and animals. De Gruyter, Berlin New York, pp 546\u2013560","DOI":"10.1515\/9783110200171.9.546"},{"key":"1070_CR39","unstructured":"Arbeitskreis Krankenhaus- und Praxishygiene der AWMF (2007) Prophylaxe der Creutzfeldt-Jakob-Erkrankung in Krankenhaus und Praxis. Hyg Med 7\/8:301\u2013306"},{"key":"1070_CR40","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000077053","volume":"11","author":"Beekes","year":"2004","unstructured":"Beekes M, Mielke M, Pauli G et al (2004) Aspects of risk assessment and risk management of nosocomial transmission of classical and variant Creutzfeldt-Jakob disease with special attention to German regulations. Contrib Microbiol 11:117\u2013135","journal-title":"Contrib Microbiol"},{"key":"1070_CR41","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s00103-003-0761-8","volume":"47","author":"Bertram","year":"2004","unstructured":"Bertram J, Mielke M, Beekes M et al (2004) Inaktivierung und Entfernung von Prionen bei der Aufbereitung von Medizinprodukten. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 47:36\u201340","journal-title":"Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz"},{"key":"1070_CR42","unstructured":"Department of Health (2010) Guidance from the ACDP TSE working group. http:\/\/www.dh.gov.uk\/ab\/ACDP\/TSEguidance\/DH_098253"},{"key":"1070_CR43","unstructured":"National Institute for Health and Clinical Excellence (NICE) (2006) Patient safety and reduction of risk of transmission of Creutzfeldt-Jakob disease (CJD) via interventional procedures. http:\/\/www.nice.org.uk\/IPG196"},{"key":"1070_CR44","unstructured":"Department of Health (2006) The decontamination of surgical instruments with special attention to the removal of proteins: and inactivation of any contaminating human prions \u2013 2006 report. http:\/\/www.dh.gov.uk\/en\/Publicationsandstatistics\/Publications\/PublicationsPolicyAndGuidance\/DH_072443"},{"key":"1070_CR45","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s00103-002-0393-4","volume":"45","author":"Task","year":"2002","unstructured":"Task Force vCJK (2002) Die Variante der Creutzfeldt-Jakob-Krankheit (vCJK). Epidemiologie, Erkennung, Diagnostik und Pr\u00e4vention unter besonderer Ber\u00fccksichtigung der Risikominimierung einer iatrogenen \u00dcbertragung durch Medizinprodukte, insbesondere chirurgische Instrumente \u2013 Abschlussbericht der Task Force vCJK zu diesem Thema. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 45:376\u2013394","journal-title":"Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz"},{"key":"1070_CR46","unstructured":"(o A) (1996) Desinfektion und Sterilisation von chirurgischen Instrumenten bei Verdacht auf Creutzfeldt-Jakob-Erkrankungen. Bundesgesundheitsblatt 39:282\u2013283"},{"key":"1070_CR47","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF03042975","volume":"41","author":"Simon","year":"1998","unstructured":"Simon D, Pauli G (1998) Krankenversorgung und Instrumentensterilisation bei CJK-Patienten und CJK-Verdachtsf\u00e4llen. Bundesgesundheitsblatt 41:279\u2013285","journal-title":"Bundesgesundheitsblatt"},{"key":"1070_CR48","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s00103-001-0279-x","volume":"44","author":"Kommission","year":"2001","unstructured":"Kommission f\u00fcr Krankenhaushygiene und Infektionspr\u00e4vention und Bundesinstitut f\u00fcr Arzneimittel und Medizinprodukte (2001) Gemeinsame Empfehlung der Kommission f\u00fcr Krankenhaushygiene und Infektionspr\u00e4vention und des Bundesinstitutes f\u00fcr Arzneimittel und Medizinprodukte \u2013 Anforderungen an die Hygiene bei der Aufbereitung von Medizinprodukten. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 44:1115\u20131126","journal-title":"Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz"},{"key":"1070_CR49","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jhin.2009.03.024","volume":"72","author":"Lehmann","year":"2009","unstructured":"Lehmann S, Rauwel GPM, Rogez-Kreuz C et al (2009) New hospital disinfection processes for both conventional and prion infectious agents compatible with thermosensitive equipment. J Hosp Infect 72:342\u2013350","journal-title":"J Hosp Infect"},{"key":"1070_CR50","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1099\/vir.0.016337-0","volume":"91","author":"Beekes","year":"2010","unstructured":"Beekes M, Lemmer K, Thomzig A et al (2010) Fast, broad-range disinfection of bacteria, fungi, viruses and prions. J Gen Virol 91:580\u2013589","journal-title":"J Gen Virol"},{"key":"1070_CR51","unstructured":"Department of Health (2000) Guidance on the microbiological safety of human organs, tissues and cells used in transplantation. http:\/\/www.dh.gov.uk\/en\/Publicationsandstatistics\/Publications\/PublicationsPolicyAndGuidance\/DH_4005526"},{"key":"1070_CR52","unstructured":"Human Tissue Authority (2006) HTA Directions 001\/2006. http:\/\/www.hta.gov.uk\/legislationpoliciesandcodesofpractice\/htalegaldirections.cfm"},{"key":"1070_CR53","unstructured":"Advisory Committee on the Microbiological Safety of Blood and Tissues for Transplantation (MBST) (2005) Summary of meeting of advisory committee on the microbiological safety of blood and tissues for transplantation (MSBT). http:\/\/www.advisorybodies.doh.gov.uk\/acmsbtt\/msbtsum200105.pdf"},{"key":"1070_CR54","unstructured":"Department of Health (2005) Exclusion of femoral heads from living donors \u2013 vCJD precautions. http:\/\/www.dh.gov.uk\/en\/Publicationsandstatistics\/Lettersandcirculars\/Professionalletters\/Chiefmedicalofficerletters\/DH_4114116"},{"key":"1070_CR55","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1007\/s00103-005-1142-2","volume":"48","author":"Arbeitskreis","year":"2005","unstructured":"Arbeitskreis Blut des Bundesministeriums f\u00fcr Gesundheit und Soziale Sicherung (2005) Variante Creutzfeldt-Jakob-Krankheit \u2013 Stellungnahme des Arbeitskreises Blut des Bundesministeriums f\u00fcr Gesundheit und soziale Sicherung. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 48:1082\u20131090","journal-title":"Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz"},{"key":"1070_CR56","unstructured":"Arbeitsgruppe \u201eGesamtstrategie Blutversorgung angesichts vCJK\u201c (2006) Bericht der Arbeitsgruppe \u201eGesamtstrategie Blutversorgung angesichts vCJK\u201c. http:\/\/www.rki.de\/cln_151\/nn_206134\/DE\/Content\/Infekt\/Blut\/AK__Blut\/Links\/Bericht__PEI,templateId=raw,property=publicationFile.pdf\/Bericht_PEI.pdf"},{"key":"1070_CR57","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1007\/s00103-006-1253-4","volume":"49","author":"Arbeitskreis","year":"2006","unstructured":"Arbeitskreis Blut des Bundesministeriums f\u00fcr Gesundheit (2006) Vorgehensweise bei variante Creutzfeldt-Jakob-Krankheit (vCJK) im Zusammenhang mit Blut, Plasma und Blutprodukten. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 49:396\u2013398","journal-title":"Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz"},{"key":"1070_CR58","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1365-2141.2008.07376.x","volume":"144","author":"Turner","year":"2009","unstructured":"Turner ML, Ludlam CA (2009) An update on the assessment and management of the risk of transmission of variant Creutzfeldt-Jakob disease by blood and plasma products. Br J Haematol 144:14\u201323","journal-title":"Br J Haematol"},{"key":"1070_CR59","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1007\/s00103-009-0863-z","volume":"52","author":"Arbeitskreis","year":"2009","unstructured":"Arbeitskreis Blut des Bundesministeriums f\u00fcr Gesundheit (2009) Stellungnahme zum Risiko der \u00dcbertragung von vCJK durch Plasmaderivate aus humanem Plasma. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 52:648\u2013649","journal-title":"Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz"},{"key":"1070_CR60","unstructured":"Arbeitsgruppe \u201eGesamtstrategie Blutversorgung angesichts vCJK\u201c (2008) Stellungnahme zur Entwicklung und Einf\u00fchrung von Testsystemen zum Screening von Blutspendern auf vCJK. http:\/\/www.rki.de\/cln_151\/nn_206142\/DE\/Content\/Infekt\/Blut\/AK__Blut\/Links\/StellungnahmeTestsvCJK,templateId=raw,property=publicationFile.pdf\/StellungnahmeTestsvCJK.pdf"},{"key":"1070_CR61","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1371\/journal.ppat.0020026","volume":"2","author":"Watts","year":"2006","unstructured":"Watts JC, Balachandran A, Westaway D (2006) The expanding universe of prion diseases. PLoS Pathog 2:e26","journal-title":"PLoS Pathog"}],"container-title":["Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-010-1070-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00103-010-1070-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-010-1070-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T01:59:53Z","timestamp":1685584793000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00103-010-1070-7"}},"subtitle":["Epidemiologie und Schutzma\u00dfnahmen gegen eine \u00dcbertragung von Mensch zu Mensch","Epidemiology and prevention from human to human secondary transmission"],"short-title":[],"issued":{"date-parts":[[2010,5,8]]},"references-count":61,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["1070"],"URL":"https:\/\/doi.org\/10.1007\/s00103-010-1070-7","relation":{},"ISSN":["1436-9990","1437-1588"],"issn-type":[{"value":"1436-9990","type":"print"},{"value":"1437-1588","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,8]]}}}